As of Jul 31
| -0.19 / -0.42%|
The 2 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 50.00, with a high estimate of 51.00 and a low estimate of 49.00. The median estimate represents a +10.72% increase from the last price of 45.16.
The current consensus among 3 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.